Rigel Pharmaceuticals, Inc. (RIGL) Social Stream



Rigel Pharmaceuticals, Inc. (RIGL): $1.06

0.03 (-2.75%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add RIGL to Watchlist
Sign Up

RIGEL PHARMACEUTICALS INC (RIGL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RIGL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 4 $11 $7 $8.5 $1.14 645.61%
2022-03-02 4 $11 $7 $8.25 $1.14 623.68%
2022-05-03 5 $11 $4 $7.4 $1.14 549.12%
2022-05-05 5 $11 $4 $7.2 $1.14 531.58%
2022-06-09 7 $7 $0.8 $2.008 $1.14 76.14%
2022-07-25 7 $7 $0.8 $2.15 $1.14 88.6%
2022-08-03 7 $7 $0.8 $2.221 $1.14 94.82%
2022-10-11 7 $15 $0.8 $3.678 $1.14 222.63%
2022-11-06 7 $15 $0.8 $3.535 $1.14 210.09%
2022-12-02 7 $15 $0.8 $3.478 $1.14 205.09%
2023-03-08 7 $15 $0.8 $3.492 $1.14 206.32%
2023-03-09 7 $15 $1.2 $4.325 $1.14 279.39%
2023-05-03 7 $15 $1.2 $3.993 $1.14 250.26%
2023-08-02 6 $15 $1.2 $4.158 $1.14 264.74%
2023-11-08 6 $15 $1.3 $4.175 $1.14 266.23%
2023-11-09 6 $15 $1 $4.041 $1.14 254.47%

The Trend in the Analyst Price Target


Over the past 25 months, RIGL's average price target has gone down $4.62.

RIGL reports an average of 231.15% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-08 7 15 0.8 3.492 1.790 95.08%
2023-03-09 6 15 1.2 3.992 1.680 137.62%
2023-03-09 6 15 1.2 4.325 1.680 157.44%
2023-08-02 6 15 1.2 4.158 1.290 222.33%
2023-11-09 6 15 1.0 4.041 0.817 394.61%

RIGL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 2 0 4 0 0 6

The Trend in the Broker Recommendations


Over the past 25 months, RIGL's average broker recommendation rating worsened by 0.66.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RIGL as an investment opportunity.

  • RIGEL PHARMACEUTICALS INC's average analyst price target is greater than 81.77% of all US stocks.
  • In the context of all US stocks, RIGEL PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1799.92% of them.
  • RIGEL PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1467.72% of stocks in the small market cap category.
  • In terms of how RIGEL PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 1424.89% of that group.

In the Pharmaceutical Products industry, ANIP, SEEL, and SIGA are the three stocks most similar to RIGEL PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for RIGL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!